Silvio Danese

Statistics

Publications

496

Citations

51.6K

H-Index

112

Active since

1997

Affiliations

Humanitas University(Current)

Inserm

IRCCS Humanitas Research Hospital

Nutrition-Génétique et Exposition aux Risques Environnementaux

Université de Lorraine

Silvio Danese is an author at Humanitas University specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and gastrointestinal inflammation.

ORCID

Publications per year

1997–2025

496

Publications

496

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

William J. Sandborn, Chinyu Su, Bruce E. Sands et al. · New England Journal of Medicine · 2017 · 1.7K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Gert Van Assche, James O. Lindsay, Marc Lémann et al. · Journal of Crohn s and Colitis · 2010 · 1.5K citations

Medicine, Pediatrics, Surgery +11

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Bruce E. Sands, William J. Sandborn, Remo Panaccione et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Epithelial NEMO links innate immunity to chronic intestinal inflammation

Arianna Nenci, Christoph Becker, Andy Wullaert et al. · Nature · 2007 · 1.1K citations · Full text

Life Sciences, Cell Biology, Immunology +14

1–5 of 496